XK and influenza: While the exact mechanism underlying the superiority of the mosaic NA nanoparticles remains unclear at present, these encouraging results could motivate further refinement, following the example of recently reported broadly reactive mosaic vaccines against influenza HA or coronavirus receptor binding domain26–30.